Communication key to cut adverse drug
events.
by Dixon, Bruce K.
Children with multiple prescriptions and those whose parents lack
English skills are at increased risk of having preventable adverse drug
events, according to a Boston study.
"Further attention should be directed toward improved
communication among health care providers and patients," said Dr.
Stephanie O. Zandieh of Cornell University, New York, and the Komansky
Center for Children's Health at New York--Presbyterian Hospital and
associates.
In the prospective cohort of patients aged under 21 years who were
seen from July 2002 to April 2003 at six urban and suburban practice
sites in Boston, the primary outcome measure was the presence of a
preventable adverse drug event (ADE), defined as actual harm from
medication use (J. Pediatr. 2008;152:225-31).
Telephone surveys were used to gather information about race,
ethnicity, reported annual family income, parental educational
attainment, and parental self-reported English proficiency.
Independent variables, such as socioeconomic characteristics,
poverty status, health care access, and medication regimen complexity,
were determined by both telephone interviews and chart reviews.
The study logged more than 21,000 visits by 14,000 patients, 3,838
of whom received a prescription. Of those, the researchers studied 1,689
patients who both completed the 10-day survey and had a chart review;
they received 2,155 prescriptions.
The study population was 49% white, 15% black, 21% Hispanic, and
14% "other"; because of rounding, these percentages do not add
up to 100%, the investigators said. Two-thirds of Hispanics studied had
limited English proficiency, compared with 16% of blacks, 3% of whites,
and 23% of the "other" group of Native Americans, Asians, and
Native Pacific Islanders.
"We found 283 ADEs occurred in 242 children (14% [of total
1,689 patients]), of which 57 were preventable in 56 children and 226
were nonpreventable ADEs in 186 children," the investigators said,
adding that about 10% of the children who had a preventable ADE also
experienced a nonpreventable event.
None of the preventable ADEs was life threatening or fatal, 14%
were serious, and 86% were considered significant. As an example of a
serious ADE, the investigators described a 9-year-old child with
streptococcal pharyngitis for whom amoxicillin was prescribed and whose
parent did not complete the course of medicine, resulting in a return
visit for persistent symptoms.
A total of 40 preventable ADEs (70%) occurred during parental
administration of medication, and 15 (26%) occurred during ordering,
they said, adding that the most common drugs involved in preventable
ADEs were amoxicillin or amoxicillin-clavulanate (26%), inhaled steroids
(11%), topical antifungals (7%), antihistamines (7%), and inhaled
bronchodilators (5%).
In their univariate analysis of the data, the researchers found
that children of parents who said they spoke English poorly were twice
as likely to have a preventable ADE, compared with children of parents
who spoke English very well.
Similarly, children with less than a year of continuous care were
more likely to have a preventable ADE than those with more continuity of
care.
In multivariate analysis, only children with multiple prescriptions
were at increased risk of having a preventable ADE.
Of no surprise was the finding that children with chronic illnesses
had more mediations prescribed, increasing their risk of a preventable
adverse event, they wrote.
"We do not believe that these findings are caused by
prescribing of less-familiar medications, because most drugs resulting
in preventable ADEs were associated with common medications, such as
antibiotics."
The more likely explanation, they added, is that providers did not
sufficiently or accurately communicate medication administration
information to parents, because most preventable ADEs occurred during
home administration.
BY BRUCE K. DIXON
Chicago Bureau
COPYRIGHT 2008 International Medical News
Group Reproduced with permission of the copyright holder. Further reproduction or distribution is prohibited without permission.
Copyright 2008 Gale, Cengage Learning. All rights
reserved. Gale Group is a Thomson Corporation Company.
NOTE: All illustrations and photos have been removed from this article.